Vericel (VCEL) Total Liabilities (2010 - 2026)
Vericel's (VCEL) quarterly Total Liabilities came in at $129.4 million in Q1 2026, little changed year-on-year from $129.1 million in Q1 2025, and down 2.95% quarter-over-quarter from $133.3 million in Q4 2025.
Vericel (VCEL) Total Liabilities (2010 - 2026) Analysis & Trends
Vericel has disclosed Total Liabilities across 17 years of filings, most recently posting $129.4 million for Q1 2026.
- Total Liabilities for Q1 2026 came in at $129.4 million, changed 0.23% year-over-year; the trailing twelve-month figure through Mar 2026 was $129.4 million (changed 0.23% YoY), and the FY2025 annual result was $133.3 million, down 5.28% from the prior year.
- Total Liabilities came in at $129.4 million for Q1 2026 at Vericel, down from $133.3 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $140.8 million in Q4 2024 to a low of $67.8 million in Q1 2022.
- The 5-year median for Total Liabilities is $127.7 million (2023), against an average of $111.5 million.
- Across the five-year window, Total Liabilities soared 72.62% in 2024 and dropped 5.28% in 2025, its largest moves.
- Vericel's Total Liabilities stood at $80.7 million in 2022, then jumped by 58.19% to $127.7 million in 2023, then grew by 10.22% to $140.8 million in 2024, then decreased by 5.28% to $133.3 million in 2025, then decreased by 2.95% to $129.4 million in 2026.
- The last three Total Liabilities figures came in at $129.4 million (Q1 2026), $133.3 million (Q4 2025), and $131.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.74 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.48 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 731.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 10.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 19.51 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 943,068.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 7.12 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 137.56 Mn |
| 10 | Vericel | 2.04 Bn | 1.90 Bn | 49.27 Mn | 129.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 129.40 Mn |
| Dec 31, 2025 | 133.33 Mn |
| Sep 30, 2025 | 131.42 Mn |
| Jun 30, 2025 | 128.80 Mn |
| Mar 31, 2025 | 129.10 Mn |
| Dec 31, 2024 | 140.76 Mn |
| Sep 30, 2024 | 132.93 Mn |
| Jun 30, 2024 | 133.86 Mn |
| Mar 31, 2024 | 122.77 Mn |
| Dec 31, 2023 | 127.71 Mn |
| Sep 30, 2023 | 113.75 Mn |
| Jun 30, 2023 | 111.78 Mn |
| Mar 31, 2023 | 71.12 Mn |
| Dec 31, 2022 | 80.73 Mn |
| Sep 30, 2022 | 70.18 Mn |
| Jun 30, 2022 | 70.00 Mn |
| Mar 31, 2022 | 67.80 Mn |
| Dec 31, 2021 | 73.24 Mn |
| Sep 30, 2021 | 67.36 Mn |
| Jun 30, 2021 | 70.85 Mn |